These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
482 related items for PubMed ID: 18186146
1. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Barrett SL, Bower C, Hadlow NC. Prenat Diagn; 2008 Jan; 28(1):28-35. PubMed ID: 18186146 [Abstract] [Full Text] [Related]
2. First trimester predictors of adverse pregnancy outcomes. Brameld KJ, Dickinson JE, O'Leary P, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R. Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038 [Abstract] [Full Text] [Related]
3. Pregnancy outcomes in unselected singleton pregnant women with an increased risk of first-trimester Down's syndrome. Liu SS, Lee FK, Lee JL, Tsai MS, Cheong ML, She BQ, Chen SC. Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1130-4. PubMed ID: 15548144 [Abstract] [Full Text] [Related]
6. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186 [Abstract] [Full Text] [Related]
7. Maternal serum free beta-hCG and PAPP-A in patients with habitual abortion-influence on first-trimester screening for chromosomal abnormalities. Heinig J, Steinhard J, Schmitz R, Nofer JR, Kiesel L, Klockenbusch W. Prenat Diagn; 2007 Sep; 27(9):814-6. PubMed ID: 17554803 [Abstract] [Full Text] [Related]
8. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Prenat Diagn; 2002 Sep; 22(9):778-82. PubMed ID: 12224070 [Abstract] [Full Text] [Related]
9. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Spencer K, Cowans NJ, Avgidou K, Nicolaides KH. Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214 [Abstract] [Full Text] [Related]
10. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Amor DJ, Xu JX, Halliday JL, Francis I, Healy DL, Breheny S, Baker HW, Jaques AM. Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467 [Abstract] [Full Text] [Related]
11. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME. Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981 [Abstract] [Full Text] [Related]
12. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester. Leung TY, Sahota DS, Chan LW, Law LW, Fung TY, Leung TN, Lau TK. Ultrasound Obstet Gynecol; 2008 Jan; 31(1):10-4. PubMed ID: 18098339 [Abstract] [Full Text] [Related]
13. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH. Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705 [Abstract] [Full Text] [Related]
14. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Am J Obstet Gynecol; 2004 Oct; 191(4):1452-8. PubMed ID: 15507982 [Abstract] [Full Text] [Related]
15. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Ardawi MS, Nasrat HA, Rouzi AA, Qari MH, Al-Qahtani MH, Abuzenadah AM. Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128 [Abstract] [Full Text] [Related]
16. Pregnancy outcome in the setting of extremely low first trimester PAPP-A levels. Scott F, Coates A, McLennan A. Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):258-62. PubMed ID: 19566556 [Abstract] [Full Text] [Related]
17. Does vaginal bleeding influence first-trimester markers for Down syndrome? Heinig J, Steinhard J, Schmitz R, Nofer JR, Witteler R, Mosel A, Ahrens A, Kiesel L, Klockenbusch W. Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311 [Abstract] [Full Text] [Related]
18. The impact of assisted reproductive technology on the association between first-trimester pregnancy-associated plasma protein a and human chorionic gonadotropin and adverse pregnancy outcomes. Zhong Y, Bradshaw R, Stanley AP, Odibo AO. Am J Perinatol; 2011 May; 28(5):347-54. PubMed ID: 21082535 [Abstract] [Full Text] [Related]
19. First-trimester combined screening for Down syndrome and other fetal anomalies. O'Leary P, Breheny N, Dickinson JE, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R. Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125 [Abstract] [Full Text] [Related]
20. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH. Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381 [Abstract] [Full Text] [Related] Page: [Next] [New Search]